Instituto Mexicano del Seguro Social clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
- Minor: GALACTUS · Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial) Trial completed
- Minor: EARLY BOT-SPAS · Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence Trial status changed: Active, Not Recruiting → Not Yet Recruiting
- Notable: Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis Study completion date changed from estimate of Apr 1, 2025 to Nov 1, 2025
- Notable: Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention Enrolling by invitation only
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-30 | NCT07907666 Ropivacaine Alone Versus Ropivacaine Plus Lidocaine With or Without Epinephrine for… | Phase 4 | Completed |
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 4 |
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Obesity (4) · Diabetes (3) · Stroke (2) · Chronic Kidney Disease (1) · Heart Disease (1) · Hypertension (1)
Get alerts when Instituto Mexicano del Seguro Social's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.